Wright Center scholar presents on nanomedicines
Wright Center scholar Guizhi “Julian” Zhu, Ph.D., presented to 35 peers across the country yesterday about his research into nanomedicines.
Zhu has worked to develop experimental treatments that use nanoparticles or functional molecules to deliver drugs directly to lymph nodes and tumors for multiple modalities of tumor therapy. His research has implications for treatments across the spectrum of care, and his fellow researchers watching virtually came from a variety of backgrounds.
Zhu is a Wright Center KL2 scholar, through which program he receives funding for dedicated research time, as well as wraparound support services for his work. An assistant professor in VCU’s School of Pharmacy, Zhu has also received funding from the Wright Center’s Endowment Fund for health sciences research.
The hour-long talk was organized by the Georgetown-Howard Universities Center for Clinical and Translational Science, a Clinical and Translational Science Award hub like the Wright Center, as part of the KL2 Visiting Scholar Program. The scholar exchange program is an opportunity for KL2 scholars to visit partner schools for professional collaboration, networking and practice sharing.
Zhu recently received one of VCU’s 31 COVID-19 Rapid Research Funding Opportunity awards, which the Wright Center helped fund. His innovative drug delivery platform may prove useful in delivering an eventual COVID-19 vaccine.
Zhu is an Assistant Professor in the Center for Pharmaceutical Engineering and Sciences and the Department of Pharmaceutics at the School of Pharmacy, as well as an associate member of VCU Massey Cancer Center’s Development Therapeutics research program, where he’s received pilot grant funding.
Categories Collaboration, KL2, Research